SG11201909564XA - Methods of preparing indolinobenzodiazepine derivatives - Google Patents

Methods of preparing indolinobenzodiazepine derivatives

Info

Publication number
SG11201909564XA
SG11201909564XA SG11201909564XA SG11201909564XA SG 11201909564X A SG11201909564X A SG 11201909564XA SG 11201909564X A SG11201909564X A SG 11201909564XA SG 11201909564X A SG11201909564X A SG 11201909564XA
Authority
SG
Singapore
Prior art keywords
international
english
pct
applicant
rule
Prior art date
Application number
Inventor
Baudouin Gérard
Richard Silva
Michael Miller
Manami Shizuka
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of SG11201909564XA publication Critical patent/SG11201909564XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 25 October 2018 (25.10.2018) WIP0 I PCT 0111111010 0111 °nolo omuliolomunom oimIE (10) International Publication Number WO 2018/195245 Al (51) International Patent Classification: C07D 487/04 (2006.01) (21) International Application Number: PCT/US2018/028253 (22) International Filing Date: 19 April 2018 (19.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/487,695 20 April 2017 (20.04.2017) US (71) Applicant: IMMUNOGEN, INC. [US/US]; 830 Winter Street, Waltham, MA 02451 (US). (72) Inventors: GERARD, Baudouin; 69 Dartmouth Street, Belmont, MA 02478 (US). SILVA, Richard, A.; 587 Greendale Avenue, Needham, MA 02492 (US). MILLER, Michael, Louis; 4 Maymont Drive, Framingham, MA 01701 (US) SHIZUKA, Manami; 253 Payson Road, Bel- mont, MA 02478 (US). (74) Agent: DAVIS, Steven, G. et al.; McCarter & English, LLP, 265 Franklin Street, Boston, MA 02110 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a 1 patent (Rule 4.17(0) 71' as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) 1 1 1-1 Published: — with international search report (Art. 21(3)) 1-1 (54) Title: METHODS OF PREPARING INDOLINOBENZODIAZEPINE DERIVATIVES \" (57) : The invention provides novel methods for preparing indolinobenzodiazepine monomer compounds and their synthetic 0 precursors.
SG11201909564X 2017-04-20 2018-04-19 Methods of preparing indolinobenzodiazepine derivatives SG11201909564XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762487695P 2017-04-20 2017-04-20
PCT/US2018/028253 WO2018195245A1 (en) 2017-04-20 2018-04-19 Methods of preparing indolinobenzodiazepine derivatives

Publications (1)

Publication Number Publication Date
SG11201909564XA true SG11201909564XA (en) 2019-11-28

Family

ID=62117004

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201909564X SG11201909564XA (en) 2017-04-20 2018-04-19 Methods of preparing indolinobenzodiazepine derivatives

Country Status (12)

Country Link
US (4) US10442809B2 (en)
EP (1) EP3612533A1 (en)
JP (2) JP7170663B2 (en)
KR (2) KR20230154089A (en)
CN (2) CN115448926A (en)
AU (2) AU2018254463B2 (en)
CA (1) CA3060086A1 (en)
IL (4) IL311609A (en)
MA (1) MA51510A (en)
SG (1) SG11201909564XA (en)
TW (1) TWI790228B (en)
WO (1) WO2018195245A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230154089A (en) 2017-04-20 2023-11-07 이뮤노젠 아이엔씨 Methods of preparing indolinobenzodiazepine derivatives
WO2023018960A1 (en) * 2021-08-13 2023-02-16 Immunogen, Inc. Improved methods for preparing cytotoxic benzodiazepine derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453266A (en) 1966-03-14 1969-07-01 American Home Prod 1,2,5-benzothiadiazepine 1,1-dioxides
US3506646A (en) 1966-06-27 1970-04-14 American Home Prod Process for the preparation of 7h-pyrido (1,2-b)(1,2,5)benzothiadiazepine 5,5 - dioxides and pyrrolo(1,2-b)(1,2,5)benzothiadiazepine 5,5-dioxides
US3875162A (en) 1973-07-26 1975-04-01 Squibb & Sons Inc Certain 6H-pyrimido{8 1,2-c{9 {8 1,3,5{9 benzothiadiaza compounds
US4003905A (en) 1974-12-11 1977-01-18 E. R. Squibb & Sons, Inc. Diels-alder adducts of benzdiazepines
US4444688A (en) 1981-05-11 1984-04-24 Ciba-Geigy Corporation Imidazobenzothiadiazepines
JP2920385B2 (en) 1988-08-18 1999-07-19 武田薬品工業株式会社 1,2,5-benzothiadiazepine derivatives, their production and use
JP3006615B2 (en) * 1989-02-08 2000-02-07 電気化学工業株式会社 Method for producing D-β-hydroxy amino acid
US6660856B2 (en) * 2002-03-08 2003-12-09 Kaohsiung Medical University Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
RU2338747C2 (en) 2003-03-31 2008-11-20 Каунсил Оф Сайентифик Энд Индастриал Рисерч DIMERS OF PYRROL[2,1-c][1,4]BENZODIAZEPINE AS ANTITUMORAL AGENTS AND METHOD OF THEIR OBTAINING
RU2314309C2 (en) 2003-03-31 2008-01-10 Каунсил Оф Сайентифик Энд Индастриал Рисерч Pyrrolo[2.1-c][1.4]benzodiazepines, method for their preparing and pharmaceutical composition based on thereof
SG10201706294VA (en) * 2009-02-05 2017-09-28 Immunogen Inc Novel benzodiazepine derivatives
KR20140010067A (en) * 2011-02-15 2014-01-23 이뮤노젠 아이엔씨 Methods of preparation of conjugates
GB201201100D0 (en) * 2012-01-20 2012-03-07 Medical Res Council Polypeptides and methods
KR102632830B1 (en) 2014-09-03 2024-02-02 이뮤노젠 아이엔씨 Cytotoxic benzodiazepine derivatives
US9381256B2 (en) 2014-09-03 2016-07-05 Immunogen, Inc. Cytotoxic benzodiazepine derivatives
ES2747386T3 (en) 2015-01-14 2020-03-10 Bristol Myers Squibb Co Heteroarylene-linked benzodiazepine dimers, conjugates thereof and methods of preparation and use
KR20230154089A (en) 2017-04-20 2023-11-07 이뮤노젠 아이엔씨 Methods of preparing indolinobenzodiazepine derivatives

Also Published As

Publication number Publication date
JP2020517625A (en) 2020-06-18
US20200109145A1 (en) 2020-04-09
IL293192B2 (en) 2024-01-01
IL270008B (en) 2022-06-01
US10442809B2 (en) 2019-10-15
CN110573510A (en) 2019-12-13
IL305224B1 (en) 2024-05-01
JP2023015178A (en) 2023-01-31
IL293192B1 (en) 2023-09-01
TW201838998A (en) 2018-11-01
TW202337888A (en) 2023-10-01
IL311609A (en) 2024-05-01
KR20190140977A (en) 2019-12-20
US20240067652A1 (en) 2024-02-29
US20180339989A1 (en) 2018-11-29
US11760759B2 (en) 2023-09-19
AU2018254463B2 (en) 2022-05-12
TWI790228B (en) 2023-01-21
RU2019136798A (en) 2021-05-20
IL293192A (en) 2022-07-01
CA3060086A1 (en) 2018-10-25
EP3612533A1 (en) 2020-02-26
KR102595714B1 (en) 2023-10-31
US20210292329A1 (en) 2021-09-23
MA51510A (en) 2020-11-11
US10968228B2 (en) 2021-04-06
RU2019136798A3 (en) 2021-09-23
JP7170663B2 (en) 2022-11-14
CN115448926A (en) 2022-12-09
IL305224A (en) 2023-10-01
WO2018195245A1 (en) 2018-10-25
KR20230154089A (en) 2023-11-07
AU2022215237A1 (en) 2022-09-01
AU2018254463A1 (en) 2019-11-07
CN110573510B (en) 2022-10-11
AU2022215237B2 (en) 2024-05-02

Similar Documents

Publication Publication Date Title
SG11201811564QA (en) Methods of treating ovarian cancer
SG11201909955XA (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
SG11201808622SA (en) Chimeric receptors to flt3 and methods of use thereof
SG11201907451XA (en) Substituted imidazo-quinolines as nlrp3 modulators
SG11201909960UA (en) Methods for improving memory and cognition and for treating memory and cognitive disorders
SG11201810420YA (en) Antibodies to alpha-synuclein and uses thereof
SG11201907840RA (en) Fused imidazo-piperidine jak inhibitors
SG11201805044WA (en) Compounds useful as kinase inhibitors
SG11201906386XA (en) Combination therapy involving diaryl macrocyclic compounds
SG11201807720TA (en) Methods and systems for determining antibiotic susceptibility
SG11201809751XA (en) Egfr inhibitor compounds
SG11201906959RA (en) Aryl hydrocarbon receptor (ahr) modulator compounds
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201909807TA (en) Methods of manufacturing of niraparib
SG11201909680UA (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
SG11201907356SA (en) Piperidine-substituted mnk inhibitors and methods related thereto
SG11201909837YA (en) Methods for treating lung disorders
SG11201805755SA (en) Methods of administering hepcidin
SG11201906666QA (en) Methods of preparing cytotoxic benzodiazepine derivatives
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201907208XA (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SG11201408171SA (en) Fbxo3 inhibitors
SG11201900123TA (en) Compositions and methods for treating frontotemporal dementia
SG11201906778RA (en) Improved methods for assessing risk of developing breast cancer
SG11201906313SA (en) A polypeptide linker for preparing multispecific antibodies